Ken Batchelor
Corporate Officer/Principal chez GlaxoSmithKline, Inc.
Profil
Ken Batchelor is currently a Senior Vice President at GlaxoSmithKline, Inc. He was formerly the Chief Scientific Officer at Fate Therapeutics, Inc. He received an undergraduate degree from the University of Durham and a doctorate degree from the University of Birmingham.
Postes actifs de Ken Batchelor
| Sociétés | Poste | Début |
|---|---|---|
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 11/07/2009 |
Anciens postes connus de Ken Batchelor
| Sociétés | Poste | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Ken Batchelor
| University of Birmingham | Doctorate Degree |
| University of Durham | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
